...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Prothrombotic responses to exercise are little influenced by clopidogrel treatment.
【24h】

Prothrombotic responses to exercise are little influenced by clopidogrel treatment.

机译:氯吡格雷治疗对运动的血栓形成反应几乎没有影响。

获取原文
获取原文并翻译 | 示例

摘要

Aims: Adenosine diphosphate (ADP) is involved in shear-induced platelet activation, which may be important for platelet responses to stress. We therefore tested the hypothesis that ADP receptor antagonism by clopidogrel treatment would attenuate exercise-induced platelet activation. Methods and results: Fifteen healthy volunteers performed exhaustive exercise without and with clopidogrel pretreatment (75 mg/day; 7 days) in a randomised crossover study. Filtragometry readings (reflecting platelet aggregability in vivo) and 11-dehydro-thromboxane B(2) (TxM) in plasma were determined before and after exercise. Platelet and leukocyte activity, platelet-platelet (PPA), and platelet-leukocyte aggregates (PLAs) in vivo and their responsiveness to agonist stimulation in vitro were assessed by flow cytometry. Clopidogrel treatment inhibited ADP-induced platelet P-selectin expression by 72% (54-85%). Exercise increased platelet aggregation (filtragometry and PPAs), elevated plasma TxM, increased single platelet P-selectin expression, elevated circulating PLAs, and enhanced ADP and thrombin-stimulated P-selectin expression. Clopidogrel prolonged filtragometry readings and attenuated agonist stimulated P-selectin expression at rest, but did not influence TxM in plasma or urine or attenuate platelet or leukocyte responses to exercise. Clopidogrel treatment did not influence plasma CD40L (ligand) at rest or after exercise. Conclusion: Clopidogrel treatment attenuates platelet activity in vivo at rest, but exercise counteracts the platelet stabilizing effects of clopidogrel. The hypothesis that ADP is involved in stress-induced platelet activation was not supported.
机译:目的:二磷酸腺苷(ADP)参与剪切诱导的血小板活化,这可能对血小板对应激的反应很重要。因此,我们检验了氯吡格雷治疗对ADP受体的拮抗作用会减弱运动引起的血小板活化的假说。方法和结果:在一项随机交叉研究中,有15名健康志愿者在不进行氯吡格雷预处理的情况下进行了力竭运动(75 mg /天; 7天)。在运动前和运动后测定血浆中的纤颤仪读数(反映体内的血小板凝集能力)和血浆11-脱氢血栓烷B(2)(TxM)。通过流式细胞术评估了体内的血小板和白细胞活性,血小板-血小板(PPA)和血小板-白细胞聚集体(PLA)以及它们对体外激动剂刺激的反应性。氯吡格雷治疗可抑制ADP诱导的血小板P选择素表达72%(54-85%)。运动可增加血小板聚集(血凝测定法和PPA),血浆TxM升高,单血小板P选择素表达增加,循环PLA升高以及ADP和凝血酶刺激的P选择素表达增加。氯吡格雷延长了纤颤仪的读数,减弱了激动剂,在静止时刺激了P-选择素的表达,但没有影响血浆或尿液中的TxM或减弱了血小板或白细胞对运动的反应。氯吡格雷治疗在静息或运动后不影响血浆CD40L(配体)。结论:氯吡格雷治疗可降低体内静止时的血小板活性,但运动会抵消氯吡格雷的血小板稳定作用。不支持ADP参与应激诱导的血小板活化的假说。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号